Report copyright - SINGLE - gskpro.com · Phase III non-inferiority, randomised, double-blind, double-dummy, multicentre study of: • DTG (50 mg QD) with ABC/3TC FDC plus ATRIPLA ® placebo
Please pass captcha verification before submit form
Please pass captcha verification before submit form